Skip to main content
. 2022 Jul 18;18(13):4901–4913. doi: 10.7150/ijbs.72318

Table 3.

Measured biomarkers of the studied groups.

Severe COVID-19 Group
N = 35
Moderate COVID-19 Group
N = 45
Control Group
N = 40
U P-value
NEAT1 Expression 1.95 0.051
Median 1626.59 1404.87 2.20 6.26 <0.0012
(Range) (0.55 - 4225.06) 174.79 - 3448.12. 0.44 - 6.97 7.93 <0.0013
TUG1 Expression 0.10 0.921
Median 623.11 664.15 0.56 7.44 <0.0012
(Range) 3.0 - 1554.18 143.03 - 1530.52 0.12 - 1.57 7.93 <0.0013
CCL2 Expression 6.44 <0.0011
Median 276678.7 17876.56 2.36 7.93 <0.0012
(Range) 2951.78 - 1007200 0.45 - 86210.41 5.01 - 7.84 5.32 <0.0013
TNF-α Expression 1.52 0.131
Median 11.83 7.77 1.35 6.48 <0.0012
(Range) 0.68 - 38 2.21 - 17.19 0 - 3.73 7.52 <0.0013
IL-6 Expression 7.65 <0.0011
Median 37877.43 21.33 0.02 7.93 <0.0012
(Range) 403.66 - 115591.9 0.47 - 310.22 0- 0.25 7.44 <0.0013

U = Mann-Whitney U test

1 = comparing severe and moderate COVID-19 groups

2 = comparing severe COVID-19 group and controls

3 = comparing moderate COVID-19 group and controls